Heronova Pharmaceuticals
6 clinical trials · Sponsor
◉ Watch Heronova Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| A Study of DC6001 Tablet in Healthy Chinese Adult Subjects (NCT07417566) | Heronova Pharmaceuticals | 2026-01-01 |
| A Study of DC50292A Tablet in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors (NCT07071090) | Heronova Pharmaceuticals | 2025-06-30 |
| A Study of DC05F01 in Chinese Patients with Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors (NCT06873555) | Heronova Pharmaceuticals | 2024-09-11 |
| Relative Bioavailability Study of CX2101A for the Treatment of COVID-19 (NCT06864182) | Heronova Pharmaceuticals | 2024-03-21 |
| A Study of CX2101A Enteric-Coated Tablets in Healthy Chinese Adult Subjects (NCT06860282) | Heronova Pharmaceuticals | 2022-12-26 |
| A Study of DC05F01 in Chinese Patients with Advanced or Metastatic Solid Tumors (NCT06873542) | Heronova Pharmaceuticals | 2022-07-08 |
Track Heronova Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.